The WATCH Adds Frequency Therapy to Standard Smartwatch Metrics
TLS launches a wearable that combines standard health tracking with proprietary frequency transmissions and a specialized band.
Key points
- The WATCH combines standard biometric tracking with on-demand frequency intervals and a continuously active supercharged band.
- TLS claims the band reduces harmful EMF exposure and supports bioelectric balance, citing studies by Dr. Glen Rein.
- The device represents a shift from passive data monitoring to active wellness intervention through proprietary energy patterns.
The Light System (TLS) has introduced The WATCH, a wearable device that integrates standard biometric monitoring with a novel approach to wellness. While the smartwatch tracks common metrics like heart rate and sleep, it differentiates itself by incorporating timed frequency transmissions and a specially engineered band. This positions the product as both a data collector and an active wellness tool, a shift from the passive observation model used by most competitors.
According to TechBullion, the device includes the expected suite of sensors for blood oxygen, HRV, and stress levels, alongside standard smartphone functions like call and message notifications. The primary distinction lies in the TLS Frequency Intervals, a feature users can activate via a swipe. The company describes these as energetic coherence transmissions intended to interact with the body’s bioelectric environment, moving the category beyond simple data logging.
A Band Designed for Active Wellness
The most significant hardware component is the supercharged band, which TLS claims remains active continuously rather than only when the watch is powered on. The company states that a proprietary process embeds the strap with specific energetic patterns, including frequencies of 7.83 Hz and 432 Hz. Unlike traditional straps that serve solely as a mount, TLS positions this band as a functional wellness component intended to support cellular electrical activity and reduce exposure to harmful electromagnetic fields (EMFs).
Users can wear the band during sleep or swap it between compatible devices without losing its intended benefits. This design choice suggests a strategy where the wellness value is decoupled from the digital interface. However, the trade-off is reliance on proprietary claims for the band's continuous efficacy, as the technology does not rely on standard battery-powered electronics in the same way the watch's sensors do.
Research Backing and Scientific Validation
TLS supports its claims through partnerships with Dr. Glen Rein, a microbiologist with extensive experience in bioelectromagnetics. His previous affiliations include Mount Sinai and Stanford Medical Center. The studies utilize Electro Impedance Spectroscopy to measure how TLS products affect bioelectric activity in human cells compared to uncharged controls. This laboratory-based validation is a notable departure from the wellness wearable market, where brands often rely on user testimonials rather than peer-reviewed or independent lab data.
The Trade-Off of Frequency Claims
Despite the research backing, the core value proposition rests on the efficacy of the frequency intervals and the supercharged band. The industry has largely optimized wearables for observation, providing users with data about their physiological state. TLS is wagering that the next competitive edge lies in active intervention, using the wrist to influence the body directly. For consumers, this introduces a new variable: the potential benefits of reduced EMF exposure and energetic coherence are currently supported by company-affiliated studies rather than independent, large-scale clinical trials.
